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For 45 African countries/territories already report-
ing COVID-19 cases before 23 March 2020, we esti-
mate the dates of reporting 1,000 and 10,000 cases. 
Assuming early epidemic trends without interventions, 
all 45 were likely to exceed 1,000 confirmed cases by 
the end of April 2020, with most exceeding 10,000 a 
few weeks later.
The World Health Organization (WHO) declared coro-
navirus disease (COVID-19) a public health emergency 
of international concern on 30 January 2020 [1] and 
then a pandemic on 11 March 2020 [2], highlighting its 
rapid global spread and risk of overwhelming health-
care services with patients requiring critical care. By 
22 April 2020, WHO situation reports (SITREPs), indi-
cated 56 African countries/territories reporting at least 
one laboratory-confirmed infection (‘reported case’) of 
COVID-19 [3]. We aim to estimate the timing of when 
countries/territories with early cases (reported before 
10:00 Central European Summer Time (CEST) 23 March 
2020, 45 of those 56) would report 1,000 and 10,000 
cases [4].
Assumptions, data sources and model used 
in the study
Reported cases underestimate actual infections due to 
the mix of those resulting in mild disease and asymp-
tomatic infections [5-7], the similarity of symptoms to 
other diseases common to lower-middle income coun-
tries [8], and the limitations of local surveillance sys-
tems [9]. However, assuming that the reporting fraction 
among actual cases and delay are constant, reported 
cases grow in proportion to the underlying epidemic, 
thus even with under-ascertainment of the number 
of actual cases, reported cases provide a useful pre-
dictor for stress on healthcare systems. We can use 
this surrogate for the real epidemic to forecast future 
trends, and understand what preparations need to be 
made now and the consequences of slow public health 
responses.
We employed a branching process model to project the 
number of future cases of COVID-19 in each country/terri-
tory. This model assumes each case produces a number 
of new cases (distributed N ∼ NegBinom(R = 2, k = 0.58), 
using the reproductive number R estimate from [10] and 
the dispersion k estimate from [11]) occurring after some 
serial interval (distributed  T ∼ LogNormal(E[X ] = 4.7, 
SD[X ] = 2.9, in days, with the distribution characterised 
by the expected value (E) and standard deviation (SD)). 
We also considered  R = 3 as a sensitivity study given 
consensus that the reproductive number has been 
higher outside of Africa [12]. We start with cases timed 
according to the first 25 (or fewer) reported cases in 
the WHO SITREPs up to 23 March 2020 (SITREP 63) [4]. 
Using those epidemic parameters and initial cases and 
dates, we simulate the accumulation of reported cases. 
We assume there are always sufficient unreported 
infections to continue transmission, and that new cases 
represent a reporting sample from both identified and 
previously unidentified transmission chains. As long as 
a constant reporting fraction and delay persists during 
this period, and unreported spread is large relative to 
reported cases (or reporting does not represent effec-
tive control), this is a reasonable approximation.
For each set of country-specific initial conditions, we 
generate n = 10,000 epidemics, discarding any that 
fade out, consistent with our assumption of unreported 
transmission chains. We identify the dates when each 
simulation run crosses 1,000 and 10,000 reported 
cases, and then evaluate the 50% and 95% quantiles 
of those dates to determine the forecast interval. 
The model was built in the R statistical programming 
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Figure 1
Distribution of times when countries/territories already reporting COVID-19 cases by 23 March 2020 arrive at 1,000 and 
10,000 reported cases, with inset map indicating median expected arrival dates by country/territory, Africa, 2020 (n = 45 
countries/territories)
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The boundaries and names shown on this map do not imply official endorsement or acceptance by the European Union.
For each country, the respective predicted dates of reaching 1,000 and 10,000 reported cases are each within coloured (dark red to yellow) 
and grey horizontal boxes, representing the 50% quantiles for these dates (i.e. 50% forecast intervals). The whiskers surrounding the boxes 
are 95% forecast intervals.
For the predicted periods of arrival at 1,000 reported cases, the horizontal boxes and whiskers are coloured according to a gradient from dark 
red to yellow. The dark red progresses to yellow as the forecast intervals of arrival to 1,000 reported cases are delayed in time.
The dashed vertical line indicates cut-off date for initial cases in the simulated epidemics.
The inset map indicates the median expected arrival dates at 1,000 reported cases by country/territory (dark red to yellow, corresponding to 
the forecast distributions); countries/territories not reporting cases by 23 March 2020 SITREP are in blue.
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Table 
Projected timing of reporting of 1,000 and 10,000 COVID-19 cases for all African countries/territories reporting cases by 23 
March 2020, assuming no change in reporting or introduction of control efforts, Africa, 2020 (n = 45 countries/territories)
Country/territory
Forecast intervals 50% (95%) 
 
around date of 1,000 reported cases 
Forecast intervals 50% (95%) 
 
around date of 10,000 reported cases
Date SI > 30
Algeria 23 Mar–28 Mar (18 Mar–05 Apr) 06 Apr–12 Apr (01 Apr–20 Apr) 12 Mar
Angola 18 Apr–29 Apr (12 Apr–17 May) 07 May–21 May (28 Apr–12 Jun) 24 Mar
Benin 15 Apr–26 Apr (08 Apr–16 May) 03 May–17 May (24 Apr–09 Jun) 19 Mara
Burkina Faso 03 Apr–08 Apr (31 Mar–15 Apr) 18 Apr–23 Apr (14 Apr–01 May) 16 Mar
Cabo Verde 17 Apr–28 Apr (11 Apr–16 May) 05 May–20 May (27 Apr–11 Jun) 13 Mara
Cameroon 02 Apr–08 Apr (27 Mar–17 Apr) 17 Apr–23 Apr (12 Apr–03 May) 27 Mar
Central African Republic 14 Apr–26 Apr (07 Apr–14 May) 02 May–18 May (23 Apr–09 Jun) 18 Mara
Chad 17 Apr–29 Apr (11 Apr–18 May) 06 May–21 May (28 Apr–12 Jun) 26 Mar
Congo 13 Apr–24 Apr (06 Apr–13 May) 30 Apr–16 May (22 Apr–06 Jun) 19 Mara
Côte d’Ivoire 07 Apr–15 Apr (02 Apr–02 May) 23 Apr–03 May (16 Apr–24 May) 18 Mara
Democratic Republic of the Congo 05 Apr–10 Apr (01 Apr–19 Apr) 19 Apr–25 Apr (15 Apr–06 May) 19 Mar
Djibouti 17 Apr–29 Apr (11 Apr–18 May) 05 May–21 May (27 Apr–12 Jun) 19 Mar
Egypt 20 Mar–07 Apr (09 Mar–26 Apr) 08 Apr–29 Apr (28 Mar–22 May) 19 Mar
Equatorial Guinea 12 Apr–22 Apr (06 Apr–10 May) 28 Apr–12 May (21 Apr–04 Jun) 15 Mara
Eritrea 20 Apr–02 May (11 Apr–17 May) 10 May–24 May (02 May–11 Jun) 17 Mara
Eswatini 15 Apr–26 Apr (07 Apr–15 May) 02 May–19 May (23 Apr–10 Jun) 17 Mar
Ethiopia 09 Apr–16 Apr (04 Apr–01 May) 23 Apr–02 May (18 Apr–26 May) 16 Mara
Gabon 12 Apr–23 Apr (06 Apr–10 May) 29 Apr–13 May (21 Apr–05 Jun) 14 Mar
Gambia 17 Apr–29 Apr (10 Apr–19 May) 07 May–21 May (28 Apr–12 Jun) 18 Mar
Ghana 05 Apr–10 Apr (01 Apr–17 Apr) 19 Apr–25 Apr (15 Apr–03 May) 16 Mar
Guinea 14 Apr–26 Apr (06 Apr–15 May) 01 May–18 May (22 Apr–09 Jun) 26 Mara
Kenya 08 Apr–14 Apr (03 Apr–24 Apr) 23 Apr–30 Apr (18 Apr–12 May) 13 Mar
Liberia 14 Apr–26 Apr (08 Apr–14 May) 02 May–17 May (24 Apr–09 Jun) 22 Mara
Madagascar 11 Apr–16 Apr (08 Apr–25 Apr) 25 Apr–01 May (21 Apr–11 May) 21 Mar
Mauritania 12 Apr–24 Apr (06 Apr–14 May) 02 May–17 May (23 Apr–07 Jun) 19 Mar
Mauritius 10 Apr–17 Apr (06 Apr–01 May) 25 Apr–03 May (19 Apr–25 May) 20 Mar
Mayotte 08 Apr–12 Apr (04 Apr–19 Apr) 21 Apr–27 Apr (17 Apr–05 May) N/A
Morocco 30 Mar–06 Apr (24 Mar–16 Apr) 14 Apr–21 Apr (08 Apr–04 May) 13 Mar
Mozambique 19 Apr–30 Apr (13 Apr–19 May) 08 May–23 May (29 Apr–14 Jun) 24 Mar
Namibia 12 Apr–25 Apr (05 Apr–13 May) 30 Apr–16 May (22 Apr–07 Jun) 17 Mar
Niger 17 Apr–29 Apr (11 Apr–19 May) 07 May–22 May (28 Apr–12 Jun) 19 Mar
Nigeria 31 Mar–09 Apr (23 Mar–18 Apr) 16 Apr–24 Apr (09 Apr–04 May) 18 Mar
Réunion 04 Apr–11 Apr (31 Mar–23 Apr) 19 Apr–27 Apr (14 Apr–11 May) 14 Mar
Rwanda 06 Apr–12 Apr (02 Apr–22 Apr) 21 Apr–28 Apr (16 Apr–11 May) 14 Mar
Senegal 28 Mar–04 Apr (23 Mar–12 Apr) 11 Apr–18 Apr (07 Apr–29 Apr) 15 Mara
Seychelles 10 Apr–19 Apr (05 Apr–08 May) 26 Apr–09 May (20 Apr–02 Jun) 22 Mar
Somalia 15 Apr–27 Apr (06 Apr–12 May) 05 May–19 May (27 Apr–06 Jun) 31 Mara
South Africa 29 Mar–04 Apr (26 Mar–15 Apr) 12 Apr–19 Apr (09 Apr–03 May) 15 Mar
Sudan 13 Apr–25 Apr (05 Apr–14 May) 30 Apr–17 May (22 Apr–08 Jun) 14 Mar
Togo 07 Apr–13 Apr (30 Mar–19 Apr) 21 Apr–27 Apr (15 Apr–05 May) 20 Mara
Tunisia 30 Mar–04 Apr (25 Mar–11 Apr) 13 Apr–18 Apr (08 Apr–27 Apr) 09 Mar
Uganda 15 Apr–23 Apr (10 Apr–08 May) 30 Apr–10 May (24 Apr–31 May) 18 Mar
Tanzania 11 Apr–18 Apr (06 Apr–02 May) 25 Apr–04 May (20 Apr–26 May) 18 Mar
Zambia 15 Apr–27 Apr (09 Apr–15 May) 04 May–19 May (25 Apr–11 Jun) 20 Mar
Zimbabwe 17 Apr–28 Apr (11 Apr–17 May) 07 May–21 May (28 Apr–11 Jun) 23 Mar
COVID-19: coronavirus disease; N/A: data not available; SI: stringency index.
a Denotes countries where the date is estimated by manually coding from [17].
As a general assessment of the validity of assuming limited impact of control measures during the timeframe modelled, the last column 
denotes the date the SI [18] surpassed 30. The SI is an amalgamation of several intervention policies, which measures their formal 
declaration, and does not imply anything about their effectiveness.
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Figure 2
Forecast validation for countries having already reached 1,000 cases, 2020 (n = 39 countries)
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For each country, the predicted date of reaching 1,000 reported cases is within a black horizontal box, representing the 50% quantiles for the 
date (i.e. 50% forecast interval). The grey whiskers surrounding the boxes are 95% forecast intervals. The dot indicates the actual date when 
1,000 reported cases were reached, with white, blue or red colours respectively signalling whether this date falls within the 50% forecast 
interval, outside the 50% forecast interval but still within the 95% interval, or outside the 95% interval.
For actual reporting dates, 17/39 fell within the 50% prediction intervals, and 31/39 within the 95%.
Inset distribution indicates randomisation results: actual forecast (red) vs randomly assigned forecast (grey), with 0.975 quantile indicated by 
the line.
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language, using the  bpmodels  package [13], and 
the  data2019nCoV  package for the SITREP data [14]. 
All analysis code is available at  https://github.com/
SACEMA/COVID10k.
Projected timing of 1,000 and 10,000 
COVID-19 case reporting in considered 
African countries/territories
We projected that all of the 45 African countries report-
ing cases prior to 23 March 2020 were likely to pass 
1,000 reported cases by the end of April 2020 and 
10,000 within another few weeks (Figure 1 and Table). 
Of particular concern is that passing these thresh-
olds is largely synchronised continent-wide and real 
disease burden will certainly exceed reported cases. 
Assuming R = 3 instead, reporting of 1,000 cases occurs 
roughly 1 week earlier, and 10,000 cases 2 weeks ear-
lier. However, early trends in cases for the  R = 3 sce-
nario rapidly exceeded observed reporting, indicating 
epidemiological differences; whether those distinc-
tions are in transmission or surveillance and response 
remains to be determined.
Since our projections assume failed containment of 
initial cases and no interventions reducing early trans-
mission, they are pessimistic relative to any benefits of 
local (e.g. those summarised by the stringency index 
(SI) in  the Table) or global action. The international 
control efforts and travel restrictions to date likely 
slowed seeding of the epidemic, and other local efforts 
may have slowed spread once the epidemic was estab-
lished. However, containment measures, e.g. travel 
restrictions, increased testing, contact tracing, isola-
tion of cases and quarantine of contacts, are likely to 
slow, but not halt, real epidemic growth [15]. Indeed, 
increased testing may accelerate the time to reporting 
these numbers, as improved ascertainment increases 
the identified fraction of real cases. However, the 
model also optimistically assumes surveillance capac-
ity is not overwhelmed or stymied, which would slow 
reaching 1,000 reported cases while the real disease 
burden grows uncontrolled. This model also assumes 
a homogeneous population, neglecting urban vs rural 
differences as well as connectivity between regions, 
distinctions, which would tend towards many small out-
breaks, rather than the single one we model. Because 
we ignore these effects, the model is only appropriate 
for short-range forecasts.
Validation of the model
As model validation, we applied this same forecast-
ing approach to the 39 countries worldwide that had 
exceeded 1,000 reported cases by 7 April (SITREP 78) 
[16]; we did not consider those with more than 10,000 
cases, as they all underwent substantial control meas-
ures modifying epidemic growth. We found that 17/39 
of actual reporting dates fell within the 50% prediction 
intervals, and 31/39 within the 95% interval (Figure 2), 
indicating the forecast prediction interval is too certain, 
as expected for a rapid but low detail model. We fur-
ther showed that forecast performance is not a random 
outcome by performing a randomisation test: we shuf-
fle the assignment of forecast days-to-1,000-cases to 
different countries, and score 1,000 shuffled predic-
tions; the real forecast score is significantly different 
from random at the p < 0.001 level (Figure 2 inset).
Specific to Africa as of SITREP 93 (22 April 2020), 
Egypt, Morocco, and South Africa actually reached 
1,000 reported cases at a date falling within their 50% 
forecast interval, and Algeria within its 95% interval; 
Cameroon and Ghana reported 1,000 cases later than 
their 95% interval. For 18 other countries the upper 
time limit of the 50% forecast interval had already been 
reached on 22 April, with 11 still in their 95% interval; 
one of those had > 900 cases (Côte d’Ivoire). Of the 
seven now past their 95% interval (Burkina Faso, DR 
Congo, Nigeria, Rwanda, Senegal, Togo, Tunisia), one 
has > 900 cases (Tunisia) and the others generally had 
early interventions (SI column in the Table).
Conclusions
Using reporting to date, and assuming similar epide-
miological trends to those seen globally, we projected 
that all of the 45 African countries/territories reporting 
early cases were likely to report 1,000 cases by the end 
of April 2020, and 10,000 within another few weeks; 
with reported cases lagging and under-representing 
actual burden. Even considering reporting delays, tim-
ing is largely synchronised continent-wide. Our projec-
tions assumed no substantive changes between the 
initially reported cases and the forecast points; while 
some countries have taken drastic actions, invalidat-
ing those assumptions, others have not or have acted 
slowly (SI column in the Table). As seen outside Africa, 
because onset of severe symptoms can be delayed 
weeks from infection and last several weeks, interven-
tions have limited immediate impact on new hospi-
talisations or healthcare facility demand, meaning that 
most of the countries in our projection would be well 
past 1,000 real cases by the time the effects of inter-
ventions started in late March would be observed.
These results call for further preparations across Africa 
to ready healthcare systems and citizens for the incom-
ing wave of infections leading to COVID-19; many coun-
tries are already making these changes, but more may 
be required. Augmented staffing, personal protective 
equipment stores and training, general isolation beds 
and equipped critical care units are all urgently needed. 
Citizen awareness will also be critical, and officials 
should continue to promote preventive measures such 
as physical distancing and regular hand washing.
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